CT Scans #11 and a New Attitude
It has now been three years and five months since I was diagnosed with stage 4 adenocarcinoma of the lung. It has been three years and two months that I have been taking Xalkori, the oral chemotherapeutic agent that has kept me around this long. I was taking Xalkori for three years prior to it being FDA approved for ROS1 mutation driven lung cancer. On March 11, 2016, Xalkori was approved - which doesn't change much for me, but will make the medication more accessible to those whose insurance companies denied coverage for it because it wasn't approved. http://www.businesswire.com/news/home/20160311005839/en/XALKORI%C2%AE-crizotinib-Approved-U.S.-FDA-Treatment-Patients California poppies...one of my favorites. The clinical trial for Xalkori use with ROS1-mutation driven lung cancer found, that for patients like me, the median "duration of response", (the time the medication worked before it stopped working), is 1...